WallStreetZenWallStreetZen

NASDAQ: GRAL
Grail Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GRAL

Based on 3 analysts offering 12 month price targets for Grail Inc

Min Forecast
$100.00+12.52%
Avg Forecast
$105.00+18.15%
Max Forecast
$110.00+23.78%

Should I buy or sell GRAL stock?

Based on 3 analysts offering ratings for Grail Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GRAL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates GRAL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GRAL stock forecasts and price targets.

GRAL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-02
lockedlocked$00.00+00.00%2025-11-17
lockedlocked$00.00+00.00%2025-11-12

1 of 1

Forecast return on equity

Is GRAL forecast to generate an efficient return?

Company
-16.66%
Industry
13.51%
Market
211.58%
GRAL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GRAL forecast to generate an efficient return on assets?

Company
-14.35%
Industry
16.71%
GRAL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GRAL earnings per share forecast

What is GRAL's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$11.76
Avg 2 year Forecast
-$10.95
Avg 3 year Forecast
-$10.51

GRAL revenue forecast

What is GRAL's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$176.2M+24.24%
Avg 2 year Forecast
$212.7M+49.96%
Avg 3 year Forecast
$279.5M+97.08%
GRAL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GRAL revenue growth forecast

How is GRAL forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
24.49%
Industry
7.83%
Market
23.07%
GRAL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GRAL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GRAL vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
GRAL$88.87$105.00+18.15%Strong Buy
BLLN$89.29$137.83+54.37%Strong Buy
TWST$32.39$40.67+25.55%Strong Buy
SHC$17.69$18.00+1.75%Buy
NEO$11.76$11.20-4.76%Strong Buy
View Top Diagnostic & Research Stocks

Grail Stock Forecast FAQ

Is Grail Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: GRAL) stock is to Strong Buy GRAL stock.

Out of 3 analysts, 2 (66.67%) are recommending GRAL as a Strong Buy, 0 (0%) are recommending GRAL as a Buy, 1 (33.33%) are recommending GRAL as a Hold, 0 (0%) are recommending GRAL as a Sell, and 0 (0%) are recommending GRAL as a Strong Sell.

If you're new to stock investing, here's how to buy Grail stock.

What is GRAL's earnings growth forecast for 2026-2028?

(NASDAQ: GRAL) Grail's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 19.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.61%.

Grail's earnings in 2026 is -$406,241,000.On average, 6 Wall Street analysts forecast GRAL's earnings for 2026 to be -$458,321,792, with the lowest GRAL earnings forecast at -$453,464,607, and the highest GRAL earnings forecast at -$448,607,422. On average, 6 Wall Street analysts forecast GRAL's earnings for 2027 to be -$427,042,457, with the lowest GRAL earnings forecast at -$444,295,988, and the highest GRAL earnings forecast at -$401,536,388.

In 2028, GRAL is forecast to generate -$409,746,044 in earnings, with the lowest earnings forecast at -$470,655,768 and the highest earnings forecast at -$339,320,760.

What is GRAL's revenue growth forecast for 2026-2028?

(NASDAQ: GRAL) Grail's forecast annual revenue growth rate of 24.49% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.83%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.07%.

Grail's revenue in 2026 is $141,827,000.On average, 6 Wall Street analysts forecast GRAL's revenue for 2026 to be $6,869,057,515, with the lowest GRAL revenue forecast at $6,188,817,723, and the highest GRAL revenue forecast at $7,433,130,282. On average, 6 Wall Street analysts forecast GRAL's revenue for 2027 to be $8,290,739,188, with the lowest GRAL revenue forecast at $6,609,046,087, and the highest GRAL revenue forecast at $9,848,078,996.

In 2028, GRAL is forecast to generate $10,895,921,151 in revenue, with the lowest revenue forecast at $7,029,274,451 and the highest revenue forecast at $13,147,144,529.

What is GRAL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: GRAL) forecast ROA is -14.35%, which is lower than the forecast US Diagnostics & Research industry average of 16.71%.

What is GRAL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year GRAL price target, the average GRAL price target is $105.00, with the highest GRAL stock price forecast at $110.00 and the lowest GRAL stock price forecast at $100.00.

On average, Wall Street analysts predict that Grail's share price could reach $105.00 by Dec 2, 2026. The average Grail stock price prediction forecasts a potential upside of 18.15% from the current GRAL share price of $88.87.

What is GRAL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GRAL) Grail's current Earnings Per Share (EPS) is -$10.67. On average, analysts forecast that GRAL's EPS will be -$11.76 for 2026, with the lowest EPS forecast at -$11.63, and the highest EPS forecast at -$11.51. On average, analysts forecast that GRAL's EPS will be -$10.95 for 2027, with the lowest EPS forecast at -$11.40, and the highest EPS forecast at -$10.30. In 2028, GRAL's EPS is forecast to hit -$10.51 (min: -$12.07, max: -$8.70).

What is GRAL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: GRAL) forecast ROE is -16.66%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.